Cross-national study of the extent of anti-anxiety-sedative drug use

The New England Journal of Medicine
M B BalterD I Manheimer


No abstract listed.


Jun 1, 1973·Archives of General Psychiatry·H J ParryD I Manheimer
Nov 1, 1973·The American Journal of Psychiatry·D I ManheimerH J Parry
Nov 1, 1971·Archives of General Psychiatry·G D MellingerD I Manheimer

❮ Previous
Next ❯


Aug 1, 1979·Journal of Clinical Pharmacology·F O Anderson, F S Abuzzahab
Jan 1, 1991·European Journal of Clinical Pharmacology·A WesslingB Westerholm
Jan 1, 1987·European Journal of Clinical Pharmacology·H R OchsR I Shader
Feb 1, 1993·Social Psychiatry and Psychiatric Epidemiology·C TurrinaO Siciliani
Jan 1, 1989·European Archives of Psychiatry and Neurological Sciences·H R WackerC Schlösser
Sep 1, 2004·European Journal of Clinical Pharmacology·Rajaa LagnaouiNicholas Moore
Apr 1, 1983·Neuropharmacology·M Lader, H Petursson
Jul 1, 1989·Journal of Affective Disorders·D Turkington, P Gill
Nov 1, 1983·Archives of Gerontology and Geriatrics·K Morgan
Aug 1, 1981·Social Science & Medicine. Part E, Medical Psychology·K Koumjian
Jan 1, 1982·Social Science & Medicine·R Cooperstock, P Parnell
Jan 1, 1982·Social Science & Medicine·J MurrayA Clare
Jan 1, 1984·Social Science & Medicine·E Riska, T Klaukka
Jan 1, 1991·Social Science & Medicine·J Gabe, M Bury
Feb 1, 1993·Social Science & Medicine·D IsacsonM Dahlström
Jan 1, 1978·Neuroscience·M Lader
Sep 1, 1993·Addictive Behaviors·S N Deshpande, R S Nagpal
Oct 1, 1980·Psychosomatics·L E Hollister
Aug 1, 1985·The Journal of the Royal College of General Practitioners·A Clift
Aug 3, 1985·Lancet
Jul 15, 1999·Social Science & Medicine·P P GroenewegenW Worm
Mar 1, 1997·Journal of Clinical Epidemiology·M J DealbertoL Berkman
Feb 1, 1984·Psychological Medicine·M H LaderH Petursson
Mar 1, 1995·Psychological Medicine·I NiedhammerM J Marne
Aug 1, 1981·Psychological Medicine·J MurrayA Tarnopolsky
Jun 27, 1974·The New England Journal of Medicine·R F Maronde, M Silverman
May 13, 1993·The New England Journal of Medicine·R I Shader, D J Greenblatt
Jan 1, 1983·Journal of Psychoactive Drugs·J Marks
Jun 1, 1978·The British Journal of Addiction to Alcohol and Other Drugs·C Allgulander, S Borg
Jan 1, 1978·Acta Psychiatrica Scandinavica. Supplementum·M H Lader
Jan 1, 1978·Acta Psychiatrica Scandinavica. Supplementum·A Bliding
Jun 18, 1977·British Medical Journal·D C SkeggJ Perry
Oct 7, 1978·British Medical Journal·P Tyrer
Sep 5, 1981·British Medical Journal·H Petursson, M H Lader
Aug 3, 1974·British Medical Journal

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.